Fibric Acids
- Name
- Fibric Acids
- Accession Number
- DBCAT001018 (DBCAT002705)
- Description
Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.
- ATC Classification
- Drugs
Drug Drug Description Clofibrate A fibric acid derivative used to treat hypertriglyceridemia and high cholesterol. Gemfibrozil A lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia. Bezafibrate A lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder. Etofibrate Etofibrate is a fibrate produced by the combination of clofibrate ester linked to niacin. These components separate in the body slowly allowing for pharmacokinetics similar to controlled-release formulations. Simfibrate Not Annotated Clofibride Not Annotated Fenofibric acid A fibrate used to treat severe hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. Fenofibrate A peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia. Ciprofibrate Not Annotated Ronifibrate Not Annotated Aluminium clofibrate Not Annotated - Drugs & Drug Targets